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Tuberculosis remains a signiﬁcant disease of animals and humans worldwide. Bovine tuberculosis is caused by Mycobacteria
with an extremely wide host range and serious, although currently probably underdiagnosed, zoonotic potential. Where bovine
tuberculosis controls are eﬀective, human zoonotic TB, due to Mycobacterium bovis or M. caprae, is uncommon and clinical cases
are infrequent in cattle. Therefore, the control and ultimate eradication of bovine tuberculosis is desirable. Tuberculin tests are the
primary screening tool used in bovine eradication. The choice of tuberculin test is dependent on the environment in which it is
to be used. Tuberculin potency is critical to test performance, and the accurate determination of potency is therefore particularly
important.Thedesignofacontroloreradicationprogrammeshouldtakeintoconsiderationthefundamentalscientiﬁcknowledge,
theepidemiologicalproﬁleofdisease,theexperienceofothereradicationprogrammes,andthepresence,inthesameecosystem,of
maintenance hosts, in which infection is self-sustaining and which are capable of transmitting infection. A control or eradication
programme will necessarily require modiﬁcation as it progresses and must be under constant review to identify the optimal
desirable goals, the eﬃcacy of policy, and constraints to progress.
1.Introduction
All members of the closely related phylogenic grouping
of Mycobacteria known collectively as the M. tuberculosis
complex may cause tuberculosis in a range of species includ-
ing man. Some members of this group are predominantly
human (M. tuberculosis, M. africanum, M. canetti)o rr o d e n t
pathogens (M. microti), whereas others have a wide host
spectrum (M. bovis, M. caprae)[ 1, 2]. Hewinson et al.
recently expanded the “phylogenetic analysis of strains of
the M. tuberculosis complex to include single nucleotide
mutationsanddeletionsofspoligotypeunits”andconcluded
that “this group of organisms might best be described as
a series of host adapted ecotypes, each with a diﬀerent
host preference representing diﬀerent niches” [3]. Originally
M. caprae had been considered to be a subspecies of either
M. tuberculosis or M. bovis;h o w e v e r ,i ti sn o wa p p a r e n tt h a t
phylogenetically it preceded M. bovis and it is only since
the development of genotyping techniques allowing greater
discrimination that its existence became apparent [2].
2.BovineTuberculosis
In cattle the most important causes of tuberculosis—bovine
TB (bTB)—are M. bovis and M. caprae, both of which cause
infectious disease that may result in signiﬁcant productivity
problems due to ill health [2, 4–6]. M. bovis has one of the
broadest host ranges of all known pathogens and has been
diagnosed worldwide. O’Reilly and Daborn citing various
authorslistthespeciesinwhichthediseasehasbeenreported
as domesticated and feral cattle, goat, pig, sheep, horse,
cat, dog, fennec fox, deer, bison, buﬀalo, badger, possum,
hare, ferret, wild and feral pig, antelope, Arabian Oryx,
camel,llama,alpaca,man,humans,andnonhumanprimates
[7]. M. bovis has also been detected in lion, hyena, kudu,
baboon, leopard, cheetah,warthog andbushpig, elk, coyotes,
meerkats, black rhinoceros, aoudad (Barbary sheep), and
Lynx [8–14]. Tuberculosis due to M. bovis or M. caprae
is a zoonotic disease with a complex epidemiological pat-
tern which includes the transmission of infection within,
and between, man, domestic animals, and wildlife. The2 Veterinary Medicine International
occurrenceofM.capraehasbeenreportedinman yE uropean
countries such as Austria, France, Germany, Hungary, Italy,
Slovenia, and the Czech Republic but to date it has not
been detected in Ireland (see [2], Department of Agriculture,
Fisheries and Food (DAFF) records unpublished). Disease
caused by M. caprae is not considered to be substantially
diﬀerent from that caused by M. bovis and the same tests can
be used for its diagnosis [15].
3. Zoonotic Implications
It is estimated that 1.5–2M people die each year from
tuberculosis of the approximately 2 billion infected persons
worldwide [16]. M. bovis infection currently accounts for
only a small percentage of reported cases but it was a major
public health problem in Europe and elsewhere, when this
organism was transmitted to man in milk from infected
cows, prior to the advent of pasteurization of milk and milk
products [7]. Thoen et al. and de la Rua-Domenech provide
several reasons why M. bovis in humans is underdiagnosed
even in developed countries [17, 18]. The consumption
of unpasteurised milk or milk products still remains a
risk for infection in countries where bTB has not been
eradicated where ethnic populations present signiﬁcantly
diﬀerent epidemiological proﬁle or where HIV is prevalent
[19–23]. Zoonotic TB was originally considered primarily as
a disease of children where the disease involved the cervical
lymph nodes (scrofula), the intestinal tract, or the meninges.
It is now increasingly being recognised that infection in
childhood is the precursor of reactivated adult disease and
that many infected children may remain asymptomatic,
undiagnosed, and untreated [24, 25]. Thus zoonotic TB is of
particular concern for developing countries, but where bTB
controls are eﬀective, human M. bovis or M. caprae isolates
are uncommon and rare in countries where bTB has been
eradicated [2, 16, 18, 22, 26, 27]. M. bovis may aﬀect humans
of any age, and while the majority opinion is that human-
to-human spread of M. bovis must be a very rare event, it
doesoccurparticularlyamongstimmunocompromisedindi-
viduals [16, 25, 28–30]. O’Reilly and Daborn also referred
to a small outbreak of tuberculosis in The Netherlands in
1994 caused by M. bovis which likely involved transmission
from human to human [7]. The control and eradication
of zoonotic TB requires the early recognition of preclinical
infection in animals and the prompt removal of any infected
animals in order to eliminate a future source of infection for
other animals and for humans [31].
4. Transmission of Infection
O’Reilly and Daborn cite Sigurdsson who pre 1945, con-
ducted experimental studies in laboratory animals which
indicated that the size of the particles carrying the mycobac-
teria is of critical importance in determining infectivity [7].
This work also refers to the ﬁndings of research workers who,
as early as the ﬁrst decade of the 20th century, demonstrated
that at least 10mg of bovine tubercle bacilli are necessary to
cause alimentary infection in calves whereas 0.01mg, a 1000
times smaller dose, produces an inhalation infection. Dean
et al. demonstrated that <10 viable bacilli are suﬃcient to
cause established tuberculosis pathology reﬂecting that seen
in naturally infected ﬁeld reactor cattle but they did not
observe a dose-related eﬀect in the pathology score up to
1,000CFUs [32].
The respiratory route is accepted as the primary method
of infection spread in all species. However, it is clear that
there are other less common methods of spread such as oral,
occupational, congenital and via wounds [17, 19, 28, 33–
37]. The postmortem evidence regarding the frequency of
tuberculosis of the mammary glands in tuberculous cows
appears to depend on the extent and duration of infection
in the cow and is thus somewhat conﬂicting. Francis quotes
incidences of 0.5–19.5% in tuberculous cows and 5–31% in
cows with generalized tuberculosis [35]. Analysis of milk in
countries with no bTB eradication programme continues
to show similar levels of M. bovis detection [38, 39]. Even
in countries with a bTB eradication programme where
unpasteurised milk is routinely fed to calves on farm, a
high prevalence of infection within those calves will indicate
the probable presence of one or more cows with M. bovis
in milk and require appropriate follow-up epidemiological
investigation [19].
The transmission of M. bovis between cattle is dependent
on a number of factors, including frequency of excretion,
route of infection, the infective dose, the period of com-
municability, and host susceptibility. It is also possible that
a range of highly speciﬁc conditions must occur for ﬁne
aerosols to be produced and for transmission to take place
[40]. Transmission and observational studies suggestthatthe
required conditions are unlikely to exist when a tuberculous
animal is in the early stages of infection [40]. This view
is also supported by studies conducted in cattle, which
have indicated that bacterial shedding is, at best, transient
and involves extremely low numbers of bacilli [41]. In
man and badgers also the risk of transmission increases as
disease progresses, and these species usually only become
highly infectious when the disease is advanced and large
numbers of organisms are being excreted [37, 42, 43]. Little
et al. demonstrated transmission between naturally infected
badgers and calves housed with them after a lapse of 6
months [44]. Field experience also indicates that cattle in
the early stages of disease or with discrete walled-oﬀ lesions
do not commonly transmit M. bovis to in-contact animals
[40, 45–47]. On balance, the current evidence suggests that
while some animals in the early stages of disease do excrete
low numbers of M. bovis, in-contact animals do not readily
acquire infection [40, 41].
4.1. Environmental Transmission. Various durations of envi-
r o n m e n t a ls u r v i v a lo fM. bovis are reported in the literature
depending on the conditions under which the research has
been conducted. Early work suggested that M. bovis is a
highly resistant organism surviving in cow faeces, for at least
5 months in winter, 4 months in autumn, 2 months in
summer up to 2 years in soil; 4 months in liquid manure
stored underground, and 1-2 months in soil during theVeterinary Medicine International 3
summer months [48]. Despite the prevalence of clinically
advanced cases of bovine tuberculosis at the time that they
were conducting their studies, early 20th Century, Williams
and Hoy comment on the great diﬃculty they experienced
in ﬁnding animals with naturally infected faeces such that
76% of samples from known tuberculous cows gave negative
results and the irregularity of positive results with naturally
infected faeces led them to conduct their work with artiﬁ-
cially infected faeces [48]. O’Reilly and Daborn also discuss
where Maddock in 1935-1936 reported grazing paddocks,
withnaturallyinfectedcowsandartiﬁciallyinfectedcalves,so
as to produce pastures with a heavier infection burden than
would be likely to occur naturally [7]. When the infected
animals were removed, tuberculosis-free calves grazed these
pastures for a 3-week period following intervals of 1, 2, and 3
months. On subsequent tuberculin testing and postmortem
examination, all the calves proved to be free from any
evidenceoftuberculosis.O’ReillyandDabornalsodetailhow
Schellner in 1959 experimentally irrigated pasture plots with
102–1012 M. bovis per ml of water and after intervals of 7,
14, and 21 days allowed 56 heifers to graze the plots [7].
Only 2 of 14 animals which grazed a plot irrigated 1 week
previously became infected; all the others remained healthy.
Little et al. failed to isolate M. bovis from a large number of
environmentalsamplestakenduringandafteratransmission
study while in the same study badger faeces were positive
for M. bovis [44]. Duﬃeld and Young, working in North
Queensland, were able to reisolate M. bovis from moist soil
heldinshadeanddarknessbutnotfromanysubstrateheldin
sunlightorfromfaecesafter4weeks[49].Theywerenotable
to reisolate M. bovis from any substrate under any condition
at or from 8 weeks. Thus, while M. bovis artiﬁcially deposited
on soil or sterilised faeces stored away from sunlight may
surviveforseveralmonths,undernaturalconditionsM.bovis
appears to die out more quickly as in-contact animals do not
readily acquire infection [7, 40, 48, 49].
4.2. Wildlife. Tuberculosis was described as a reemerging
disease at the interface of domestic animals and wildlife
by Palmer who cautioned that it will not be possible to
eradicate M. bovis from livestock until transmission between
wildlife and domestic animals is halted, and he advises that
this will require a collaborative eﬀort between stakeholders
[50]. Corner has presented a detailed review of the role
of wildlife as reservoirs of M. bovis diﬀerentiating between
those that act as maintenance hosts or disease reservoirs
and those that are spill-over or dead end hosts in which
disease is not self-sustaining and which therefore do not
maintain disease in an environment [51]. Some wildlife
species, principally the badger in the United Kingdom and
Ireland, the Australian possum in New Zealand (but not
in Australia), and previously water buﬀalo in Australia,
have been recognised as signiﬁcant reservoirs of M. bovis
with endemic self-maintaining infection in these species
constituting a major obstacle to disease control programmes
[52–54]. Wildlife infection is also an issue in other countries
such as Canada, where M. bovis reservoirs in elk and deer
cause occasional problems in livestock; Spain where M. bovis
reservoirs in deer and in particular wild boar, pose a threat
to Lynx an endangered species and South Africa where
multiple species are infected in conservation areas [8, 12, 55–
58]. In Australia, elimination of wild water buﬀalo and
feral cattle from areas where infection was endemic was
a major component of the eradication campaign [54, 59].
Postmortem surveillance, epidemiological risk assessment,
and the implementation of strict cattle movement controls
ﬁnally brought disease under control, and Australia is now
bTB-free [52, 59]. New Zealand has similarly employed
strict population control measures against infected possum
populations, and very considerable progress has been made
[54, 60]. Countries where population control measures for
infected wild populations must necessarily be limited, for
example,badgersintheUKandIrelandwherethebadgerisa
protected species, have succeeded in reducing high incidence
disease levels in cattle and maintaining them at relatively
low levels by a sustained test and cull programme such
that bTB is no longer a signiﬁcant threat to humans. While
the indications are that badgers can excrete mycobacteria
from the respiratory, digestive, and urinary tract as well
as in exudates from skin lesions transmission of M. bovis
infection among badgers appears to be mainly by the
respiratory route and, although there is an overall trend for
increased prevalence with age, the acquisition of infection
apparently occurs most frequently in young animals due to
pseudovertical transmission from mother to cub [61].
4.3. Human to Cattle Transmission. Francis described how in
Denmark and Sweden, towards the end of their respective
successful bovine TB eradication programmes, there was
concern about the risk posed to cattle herds from infected
humans [33]. O’Reilly and Daborn state that transmission
of M. bovis infection from humans to cattle is usually direct
and by the respiratory route but that indirect spread via
bedding and/or hay contaminated with urine from human
renal excreters was reported by Huitema in 1969 in The
Netherlands and by Schliesser in 1974 in Germany [7].
They provided details from Huitema as to how M. bovis
infected humans were the source of infection in 50 cattle
herds in the Netherlands where a total of 636 tuberculin
reactor cattle were identiﬁed, of which 497 were conﬁrmed
postmortem as M. bovis infected and where 24 of 50 M. bovis
infected patients had urogenital tuberculosis, the others
mostly pulmonary tuberculosis. The patients with urogenital
tuberculosis had infected 259 (41%) of the reactor animals.
Citing Schliesser they stated that, in Germany, M. bovis
infection in cattle is rare but, when it occurs, man-to-cow
transmission is a principal cause and where, in 1 study, 12
patients had infected 114 cattle in 16 diﬀerent herds: 9 of
the 12 had genitourinary tuberculosis and 1 such patient had
infected 48 cattle in 4 diﬀerent herds. In 1987 Grange and
Collins stressed that man might be a continuing important
source of disease in cattle in Ireland and that urinary tract
disease may be a hidden source of infection, and they warned
that many patients with renal tuberculosis, especially older
patients, had clear radiographs and only vague symptoms
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and also from milk on some farms in North India raising
suspicion that infection had spread from humans [39].
5.TuberculinTests
Having discovered the “Tubercle bacillus” in 1882 Koch went
on, in 1890, to demonstrate the properties of a tuberculin
he had developed. The possibility of using this tuberculin
to test cattle in order to identify those with TB was very
quickly recognised, and by 1891 cattle testing was operating
extensively [35]. Almost it would seem simultaneously the
possibility of using tuberculin and tuberculin tests as a tool
to eradicate bTB was also recognised. Bovine tuberculosis
had become a problem that was exacerbated by the gradual
intensiﬁcation of cattle production in the postindustrial
revolution era [35]. In the late 19th and early 20th Century
it appeared that the generally infectious nature of the
“Tubercle bacillus” and then also the zoonotic implications
of bTB were not well appreciated. Thus it would appear
that the motivation for control of bTB during this time
was predominantly economic [35]. Even today in many
countriesorregionstheadoptionornotofabTBeradication
programme may depend on economic factors as there are
often many other conﬂicting demands for scare resources.
Hence,whilemanyunderdeveloped countries have problems
with TB in cattle and at least some, also in wildlife, not
all have or can aﬀord compulsory or comprehensive bTB
control programmes.
Finland was the ﬁrst country, in the late 1890s, to
commence a successful bTB eradication programme [35].
It was relatively quickly established that bTB could be
eradicated by the use of tuberculin tests when these were
used with knowledge of the strengths and limitations of
the test being used. Once a test and removal programme
was commenced for bovines, the incidence of clinical cases
of bTB rapidly declined as infected animals were removed
from the population. Thus, economic losses due to bTB
declined simultaneously as the cattle population became
healthier. Buxton and Glover describe how Moussu and
Mantoux in 1908 elaborated the value of the intradermal
tuberculin test when they described the type of response it
elicited in tuberculous and nontuberculous animals [63]. By
1910 Finland was already using the, then new, intradermal
test in their eradication programme. Other countries grad-
ually also commenced eradication programmes as various
tuberculin test methodologies were developed and reﬁned.
Richie, describing a number of the diﬀerent methods of
tuberculin testing employed, speaks of the subcutaneous test
which depended on temperature records over time, a short
thermal test, the ophthalmic and palpebral tests, the double
intradermal test, the Stormont test, and the vulval test, all
nowdiscardedfromgeneraluse[64].ChristiansenandStubb
are cited by Buxton and Glover as having, in 1910, selected
the side of the neck as the site for injection of tuberculin
because it gave the most consistent results regarding the
presence or absence of tuberculosis infection in cattle [63].
Baisden et al. in 1951 conﬁrmed the greater sensitivity of
the neck over the caudal fold and that the neck is the most
sensitive site [65]. Paterson detailed how sensitivity is greater
in sites on the neck nearer the head and diminishes in sites
near the shoulder and in those adjacent to the nuchal crest,
and he recommended that injection should therefore be in
the middle third of the neck [66]. The relative sensitivities
of the diﬀerent parts of the neck were conﬁrmed by Good
et al. [67]. Paterson also detailed how the test is interpreted
primarily on a herd basis, taking into consideration the
history of the herd but with sometimes diﬃculties arising in
dealing with an individual animal [66]. Tuberculin testing of
cattle has in many areas succeeded in eradicating bTB, and
there is no doubt that where the disease was conﬁned only to
cattle a test and cull programme would succeed.
Tuberculin tests, which avail of a cell-mediated response
to Mycobacteria, have now been used for the diagnosis of
tuberculosis and preclinical infection in man and animals
for more than 100 years [68]. In humans asymptomatic
and radiographically negative persons, with no history of
BCG vaccination, who are positive to tuberculin test, are
regarded as latently infected. Only approximately 5% of
infected humans develop clinical symptoms within a year of
infection and 5–10% of latently infected persons go on to
develop chronic progressive TB owing to reactivation during
their lifetime [69]. In cattle tuberculin tests are based on
detection of the speciﬁc immunological response following
exposure to M. bovis or indeed M. caprae at some period
previously. Following exposure infection will have occurred
and either progressed or become quiescent under control by
the animal whose response is based on the infective dose and
its own inherent immune system.
Monaghan reviewed the most common tuberculin tests
in use today, namely, the caudal fold test (CFT) and the
Single intradermal test (SIT) which both use only bovine
tuberculin PPD and the Single intradermal comparative
tuberculin test (SICTT), which uses bovine and avian tuber-
culin PPD in combination [68]. The use of the word single
in describing these tuberculin tests distinguishes them from
the now obsolete double intradermal test, which regards the
ﬁrst injection of tuberculin as a “sensitising” injection. There
areanumberofnationalbTBeradicationprogrammesinthe
Europe Union using either the SIT or SICTT where, when
one or more animals in a herd show a positive response
to the test, statutory controls are applied at herd level [70,
71]. Both the SIT and SICCT methodologies including test
interpretationandtestintervalsaredescribedintheEUtrade
Directive 64/432/EEC and also by the OIE [15, 72]. The
SICTT has been used extensively in the Irish bTB eradication
programme and has proven to be a very safe means to test
and screen the Irish cattle population [73]. The caudal fold
test is widely used in the USA and New Zealand and was
also used in Australia during their bovine TB eradication
campaign. There are also other regions of the world where
this is the routine test of choice with or without use of the
SICTT before animal removal.
To assess the eﬃcacy of a particular tuberculin test
methodology various parameters such as the test sensitiv-
ity, speciﬁcity, and predictive value are evaluated for the
environment, the level of disease in the population, and
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than one type of test is available, the relative values of these
appraisals will dictate which test may be most useful in
particular situations in order to maximise the performance
of the test. In 1959 Ritchie pointed out that it is vital
to use a tuberculin of potency greater than that to which
the majority of infected animals will respond [64]. The
balance of evidence appears to favour the use of tuberculin
of suﬃcient potency for the detection of tuberculosis in
cattle for the eradication of the disease. In several countries,
bovine tuberculin is considered to be of acceptable potency
if its estimated potency guarantees per bovine dose at least
2000 IU (±25%) in cattle. Field trials have conﬁrmed the
scientiﬁc basis supporting this potency level [75]. In cattle
with diminished allergic sensitivity, a higher dose of bovine
tuberculinisneeded,and,innationaleradicationcampaigns,
doses of up to 5000 IU are recommended [15]. The use of
a highly potent bovine tuberculin increases the sensitivity
of the test. However, test speciﬁcity is not only inﬂuenced
by the purity, potency, and dosage of the tuberculin and
strictness of interpretation of the response in the animal it
is also inﬂuenced by sensitization of the animal. The choice
of the SICCT, being a more speciﬁc test than the Single
Intradermal test (SIT) or any other tuberculin test using
bovine PPD alone, for the Irish and UK eradication pro-
grammes, was inﬂuenced by the abundance of nonspeciﬁc
causes of sensitization. This choice was validated by Lesslie
andHebertandO’ReillyandMacClancy,in1975,whofound
that 8–12% of apparently noninfected cattle in Ireland and
the UK react positively to the SIT but not to the SICTT [74,
76]. While the single most important cause of sensitization
is exposure to M. bovis, other pathogenic mycobacteria,
for example, Mycobacterium paratuberculosis subsp. avium,
and nonpathogenic environmental Mycobacteria such as M.
hiberniae, are abundant in the Irish environment and cause
nonspeciﬁc sensitisation to bovine tuberculin PPD [77, 78].
In the majority of cases the SICTT serves to diﬀerentiate
between responses from exposure to M. bovis and other
nonspeciﬁc Mycobacteria.
5.1. Tuberculin. In 1959 Paterson described tuberculin as
the most important diagnostic agent in eradication schemes
for tuberculosis and it remains so today [66]. The methods
of preparation of tuberculin and the ways in which it has
been applied to the diagnosis of tuberculosis date from
Koch’s original “tuberculin” preparation in 1890 when he
initially thought he had discovered a cure for tuberculosis.
Monaghan remarks on how quickly the principal advantages
and problems associated with the use of tuberculin as a
diagnostic test were, within a year of its ﬁrst use, tabulated
and the conclusion drawn by a committee at the University
of Pennsylvania that “tuberculin is of value in the diagnosis
of tuberculosis in cattle” [68]. For the purpose of testing
animals modern-day tuberculin is a puriﬁed protein deriva-
tive (tuberculin PPD, bovine or avian) prepared from the
heat-treated products of growth and lysis of M. bovis or
M. avium (as appropriate) capable of revealing a delayed
hypersensitivity in an animal sensitised to microorganisms
of the same species. Administration of Tuberculin confers
no protection to acquiring infection or from progression
to clinical disease in an already infected animal. Buxton
and Glover also credited Siebert et al. with developing the
precipitation phase in the manufacture of PPD, in 1934,
so as to ensure removal of high-molecular-weight proteins,
which had previously been responsible for sensitisation of
the subject following injection. PPD also eliminated many
of the nonspeciﬁc features of the old tuberculin [63, 79].
Paterson, citing Seibert at al., claimed that the advantages
of PPD lie in the use of a pure active principle, such that
successive batches contain the same amount of protein,
the process of preparation is reproducible from batch to
batch, and the protein yield per batch constitutes a valuable
control measure [79]. Production methods have largely been
standardised and under EU Regulations Tuberculin PPD
is a licensed product required to be manufactured under
Good Manufacturing Practice conditions and to comply
with the European Pharmacopoeia and thus also conform
to OIE requirements [15, 72, 80]. The preparatory method
ensures that PPD tuberculin consists of a mixture of small
water-soluble protein molecules and this protein content
can be helpful in the chemical standardisation of tuberculin
[81]. The protein content of tuberculin, however, does not
predict its biological activity and consequently Directive
64/432/EEC as amended sets out the minimum requirement
for tuberculin potency and requires that potency assays must
be performed in guinea pigs where the response is compared
to a reference standard [72, 81]. Performance of the assay is
described by the OIE [15].
However, while these routine assays are most reliable
when carried out in tuberculous guinea pigs sensitised
with living virulent M. bovis the guinea pig potency is not
necessarily representative of the clinical potency in cattle
[66, 82–84]. Paterson recommends that guinea pigs be used
for the control at preparation with occasional check assays
in cattle but that if the type of tuberculin is changed or
if a change in character is suspected that appeal must
be to the assay in cattle [66]. Changes in manufacturing
and production procedures may also result in ﬂuctuations
in tuberculin potency and there may also be consider-
able variability in potency between batches of tuberculin,
including those produced in the same centre [83, 85, 86].
Tuberculin potency ﬂuctuation was seen during 1990–1992
associated with Good Laboratory Practice adaptations and
in 2000 associated with changes instigated as a conse-
quence of EU requirements in relation to Transmissible
Spongiform Encephalopathies (unpublished observations—
DAFF records). Therefore, periodic validation of bovine
PPD potency, on routine bovine tuberculin supply, in
naturally infected tuberculous cattle is recommended [81,
85]. According to WHO Technical Report Series no. 745,
potency testing should be performed in the animal species
and under the conditions in which the tuberculins will be
used in practice [87]. This means that bovine tuberculins
should be assayed in naturally infected tuberculous cattle.
As this requirement is diﬃcult to accomplish, routine
potency testing is conducted in guinea pigs. However,
periodic testing in tuberculous cattle remains necessary, and
standard preparations always require calibration in cattle.6 Veterinary Medicine International
The frequency of testing in cattle can be reduced if it is
certain that the standard preparations are representative
of the routine issue tuberculins and that the production
procedures guarantee consistency [15]. Notwithstanding the
EU and OIE speciﬁcations there are tuberculins of lower
potency available and care should be exercised in selecting
tuberculin as its potency has a considerable impact on test
performance [15, 67, 72, 81, 88].
5.2. Test Limitations. In common with all tests and assays
the tuberculin test is not perfect. As tuberculin eradica-
tion programmes advanced in diﬀerent countries around
the world ﬁeld experience progressively showed that not
all infected animals gave a good response to tuberculin.
Examplesofpoor responderscitedbyRitchieinclude anergic
animals or those exhibiting reactions to both avian and
mammalian tuberculin, those in advanced stage of disease,
animals with conﬁned infection notably in the udder, those
with localised infection often in the lymphatic glands that
has become inactive (latent), and periparturient cows [64].
He goes on to say that it is essential that the tuberculin be
of suﬃcient potency to produce a reaction in the maximum
number of infected animals and to use a tuberculin of
potency greater than that to which the majority of infected
animals will respond. He warns, however, that the highly
potent tuberculin required to detect bovine infection tends
to increase the frequency of reactions associated with cross-
sensitisations arising from other organisms such as the
human and avian types (M. tuberculosis and M. avium,
resp.) and other (nonpathogenic) mycobacteria. Cross-
sensitisation also appears to have caused problems during
the Danish bTB eradication programme—Ritchie quoting
Plum from 1937 and 1939 [64]. In 1962 Karlson reported
that nonspeciﬁc responses to tuberculin were seen in all
countries where eradication measures applied and that it
was a widespread problem of a serious nature [89]. Karlson
also reported that the sensitivity to mammalian tuberculin
by cattle exposed to M. tuberculosis disappears when the
human source of exposure is removed [89]. Rushford also
reported that nonspeciﬁc responses were an issue using the
single caudal fold tuberculin test in Australia [90]. Lamont
in 1947 discussed at length the phenomenon of periparturi-
ent desensitisation and that instead the calf receiving the
colostrums of an infected cow became passively sensitised
for 4–6 weeks [79]. Lamont also postulated reasons why
the test cannot succeed under certain circumstances namely
that
(1) in a case of recent infection a response has had
insuﬃcient time to develop,
(2) postmortem ﬁnding of encapsulated lesions in test-
negative animals may be because the response has
disappeared due to lack of stimulation from repeated
doses of mycobacterial antigens,
(3) lack of a positive response to tuberculin during
“active” infection occurs particularly in advanced
cases but that this desensitisation could be produced
by injecting tuberculin [79].
While tuberculin tests are imperfect, they have been
showntobeeﬀectiveandtheyhavesucceededinreducingthe
incidence of bTB and indeed many countries have succeeded
in eradicating bovine TB with their use [71, 91]. One can see
from the rapid progress Ireland made in the initial 5 years of
theircompulsoryprogrammehowquicklyacountrycanpass
from having high disease incidence (animal incidence 17%)
to having a relatively low incidence (animal incidence 0.4%)
[52]. However, such problems as described above by both
Ritchie and Lamont still exist and continue to be manifest in
eradication programmes which employ tuberculin tests [64,
79]. Delayed hypersensitivity may not develop for a period
of 3–6 weeks following infection. Thus, if a herd/animal is
suspected to have been in contact very recently with infected
animals, delaying testing should be considered in order to
reduce the probability of false-negatives. As the sensitivity of
the test is less than 100%, it is unlikely that eradication of
tuberculosis from a herd will be achieved with only a single
tuberculin test [15].
Tuberculin test-negative animals are found, at slaughter,
with evidence of encapsulated lesions conﬁrmed as caused
by M. bovis. Where there is no active infection ongoing in
the herd from which the animal was sourced the infection
appears to relate to exposure some time, even perhaps
years, previously [45]. In other cases where there is ongoing
infection in the herd of origin, it may well have been as
a result of recrudescence of tuberculosis in a previously
infected animal and there are still other herds with ongoing
problems with TB infection where perhaps desensitization
owing to successive short-interval skin tests may be a
contributing factor (see [45, 92], DAF records unpublished).
With regard to desensitisation produced by the injection
of tuberculin Buxton and Glover in 1939 cited Cuill´ ea n d
Chelle (1935) as having demonstrated a progressive loss of
skin response when several injections are made [63]. Coad
et al. have conﬁrmed that repeated SICTT led to increasing
desensitisation at subsequent tests [92]. Paterson quoting
Swindle et al. (1950) pointed out that full sensitivity at
and for 2 to 3 inches (5–7.5cm) around the tuberculin
injection site is only recovered after 6–8 weeks [66]. Ritchie
also spoke of the region immediately adjacent to the
original inoculation that had in some but not all instances
become desensitised with reactions less marked but that full
sensitivity was regained by about the 6th week [64]. Doherty
et al. and more recently Coad et al. have also conﬁrmed
this now well-recognised phenomenon [92, 93]. Coad et al.
caution that the period of desensitisation may be longer
than previously thought and that successive short-interval
skin tests will result in progressive desensitisation, which
shouldbeconsideredwhenfacedwith“inconclusive-reactor”
skin test responses [92]. They further cautioned that the
possibility of repeat testing resulting in false-negative test
outcomes in infected cattle with indeterminate test responses
also cannot be excluded.
As a management tool in eradication test interpretation
is standard or more severe dependent on the history of the
herd, the level of infection within a particular group of
cattle, and the epidemiological assessment of the outbreak.
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data analysis become more important. In addition the use of
ancillary tests, group removal, and/or full herd depopulation
may also be required to accelerate eradication. Particularly
towards the end of an eradication programme the response
to the detection of an infected herd may be full-herd
depopulation in order to ensure that no infected animals
may remain. In countries with low incidence of bTB herd
depopulation may be an eﬀective response to a serious
outbreak of bTB in a herd. Full-herd depopulation on the
other hand is unlikely to be a signiﬁcant part of the initial
stages of an eradication programme in a high incidence
country. To alleviate some of the problems experienced
with tuberculin tests considerable research eﬀorts have been
deployed in the eﬀort to develop blood based assays which
could be used either to augment or perhaps eventually
replace tuberculin testing in cattle [94–98]. Other than the
Interferon-γ assay, which is approved for use in the EU
and by the OIE as an ancillary test for the purpose of
identifying additional infected animals in known infected
herds, the majority of such assays remain at the research and
development stage [72, 94].
5.3. Development of Testing Policies. Among animal health
professionals there has been ongoing discussion concerning
thelinkagebetweenpolicyandscience[99–101],forexample
“the Role of Science in Food Policy” discussions held in
Brussels in October 2010 on the initiative of the President-
in-Oﬃce of the Council of Agriculture Ministers, Sabine
Laruelle, the Federal Public Service for Health, Food Chain
Safety, and the Environment under the Belgian Presidency
of the Council of the European Union. Adapting policy to
reﬂect scientiﬁc knowledge as it becomes available is not new
to the ﬁeld of tuberculosis. Paterson refers to the wealth of
information on the experimental and natural pathogenicity
of mycobacteria in the reports of the Royal Commissions
on tuberculosis dating from 1907, 1909, 1911, and 1913
[66]. Ritchie in the same 1959 publication referring to the
eradication of tuberculosis is quite clear that the experience
of other countries and publications in the scientiﬁc literature
of the day was taken into account when designing the British
eradicationprogramme[64].ThustheexperienceoftheUSA
where as early as 1900 measures to prevent both entries
of infected animals from Europe and disease spread within
the States commenced and where infection was eliminated
on a geographic basis formed the foundation for the
British programme. Also considered were the programmes
from Finland where tuberculosis was brought under State
control in 1898, from Denmark, where an eradication plan
was introduced in 1922, from The Netherlands, which
commenced control in Friesland early in the 20th century,
and from Canada, which introduced an accredited herd plan
in 1919. The exchange of experience between countries went
in both directions as evidenced when The Netherlands, in
order to overcome the problem of nonspeciﬁc reactions to
tuberculin occurring in tuberculosis-free areas, introduced
a comparative skin test in 1950, adopting the English
directives, which they later in turn modiﬁed [102]. In
2006 More and Good reviewed the scientiﬁc and policy
advances in the tuberculosis eradication programme in
Ireland over the previous 20 years [52]. Other authors have
also described disease epidemiology in bovines and other
species including wild-life reservoirs, disease surveillance,
risk evaluation, and risk management during control and
eradication programmes [54, 56, 59, 60].
6. Discussion and Conclusion
In countries with bTB eradication programmes, operating
onatestandcullbasis,incidencerapidlydeclinesandclinical
evidence of tuberculosis in cattle is seldom encountered
because the intradermal tuberculin test enables presumptive
diagnosis and elimination of infected animals during the
preclinical stage. Prior to the adoption of national bTB
eradication campaigns, however, clinical signs associated
with tuberculosis in cattle, with associated economic impact,
were commonly observed [15].
Research continues into test development particularly
blood-based assays [94, 96, 98]. With a view to further
reducing TB levels in cattle considerable research eﬀort is
being expended, in the UK and Ireland, on the development
of a vaccine to protect badgers from TB and thus to reduce
transmission both between badgers and from badgers to
cattle [91, 103, 104]. The UK has also been exploring the
eﬃcacy of cattle vaccination. The possibility of developing
genetic lines of cattle with higher resistance to infection with
M. bovis without impacting negatively on other desirable
genetic traits is an exciting prospect [105, 106]. Scientiﬁc
advances will undoubtedly continue and these will be
incorporated into bTB eradication or control programmes
as appropriate. Other policy adaptations will result as a
consequence of country or regional speciﬁc epidemiological
studiesand/ordataanalysis.Eradicationprogrammesshould
also be continuously monitored for eﬀectiveness, with a view
to identifying and evaluating the constraints to progress and
implementing necessary modiﬁcations to the programme as
required.
Control and eradication of bTB is a desirable objective
both from an animal health perspective and also because
of zoonotic implications. National bTB eradication pro-
g r a m m e sh a v eb e e no ra r es t i l lo p e r a t e di nm a n yc o u n t r i e s
throughout the world. Some of the South American coun-
tries, many of which have had voluntary programmes for a
numberofyears,areatthistimeconsideringimplementation
of national compulsory programmes. In other countries,
particularly in the developing world, the issue is still being
debated [38, 39]. Most Member States of the EU, having
commenced bTB eradication programmes with a high
disease incidence, are now recognised as oﬃcially TB free
underthetrading directive [72].Diﬃculties remainhowever,
in some EU member states which still run eradication
programmes, notably Greece, Ireland, Spain, UK and to a
lesser extent Italy and Portugal. Other EU countries have
intermittent or localised problems with bovine tuberculosis
and thus must maintain vigilance [2, 71, 72].
Tuberculin tests remain the primary tool for eradication
in the bovine, and the choice of which tuberculin test to8 Veterinary Medicine International
use for primary screening is dependent on the prevalence
of mycobacteria and other cross-sensitising agents in the
local environment. Tuberculin potency is critical to test
performance and thus in selecting a tuberculin supply
particular care should be taken to evaluate the potency
assays performed during the manufacturing process. The
performance of independent potency checks on tuberculin
is worthy of consideration particularly in the target species.
When clinical cases are removed and test and cull pro-
grammes are in operation in-contact animals do not readily
acquire infection. However, for eﬀective control of bTB the
diseasemustbeaddressedinallinfectedmaintenancespecies
in the same ecosystem. Consequently other species sharing
the environment with cattle must be risk assessed to identify
potential maintenance hosts, and where other species will
constitute an impediment to ﬁnal eradication of tuberculosis
in the bovine appropriate control strategies should be
developed and/or adapted taking into consideration the
experience in other countries with similar problems. Human
sources of infection must be considered during epidemio-
logical investigation of outbreaks. Data collection and data
andepidemiologicalanalysiscapabilitymustbeincorporated
into control and eradication programmes so that progress
and the constraints to progress may be evaluated. Lessons
learned elsewhere during the operation of control and erad-
ication programmes should be considered and incorporated
as appropriate. Further scientiﬁc developments in the area of
vaccine production and delivery and in genomics to breed
increasingly disease-resistant livestock can be expected to
further the goals of bovine TB eradication in the future.
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